Previous Article | Next Article ![]()
Infect Immun, January 1998, p. 272-279, Vol. 66, No. 1
Department of
Microbiology1 and
Department of
Physiology and Biophysics,2 University of
Alabama at Birmingham, Birmingham, Alabama 35294
Received 8 August 1997/Returned for modification 9 October
1997/Accepted 31 October 1997
Murine chronic respiratory disease is characterized by persistent
colonization of tracheal and bronchial epithelial cell surfaces by
Mycoplasma pulmonis, submucosal and intraluminal immune and inflammatory cells, and altered airway activity. To determine the
direct effect of M. pulmonis upon transepithelial ion
transport in the absence of immune and inflammatory cell responses,
primary mouse tracheal epithelial cell monolayers (MTEs) were apically infected and assayed in Ussing chambers. M. pulmonis-infected MTEs, but not those infected with a nonmurine
mycoplasma, demonstrated reductions in amiloride-sensitive
Na+ absorption, cyclic AMP, and cholinergic-stimulated
Cl Mycoplasmas, the smallest
free-living prokaryotes, continue to be a significant cause of
respiratory infections in a variety of animals, including humans
(44). Their limited biosynthetic capability dictates that
these organisms must both colonize and parasitize epithelial cell
surfaces. It is therefore surprising that mycoplasmas produce diseases
that are slowly progressing and chronic and yet often clinically
inconspicuous. The molecular mechanisms responsible for this tenuous
truce between the pathogen and the host cell have not yet been
identified. Murine respiratory mycoplasmosis, a naturally occurring
respiratory disease in laboratory rats and mice caused by
Mycoplasma pulmonis (6, 8) and characterized by
chronic, often lifelong tracheitis, bronchopneumonia, and
bronchiectasis (7, 23, 28), would seem to be an ideal model
with which to study these mechanisms. Although M. pulmonis-infected animals generate intense local and systemic
immune responses (24, 33, 42, 43), they are incapable of
eliminating the organism from the respiratory epithelium. Remodeling of
the airways typically observed in infected animals, impairment of
pulmonary clearance, and accumulation of mucus (23) suggest
that M. pulmonis may compromise the ability of the
epithelial cells to absorb and secrete fluid and electrolytes.
Airway epithelial cells possess two major active transport processes,
Na+ absorption and Cl The effect of bacteria upon mammalian epithelia in the absence of
immune and inflammatory cells can be systematically evaluated by using
the Ussing chamber model. Short-circuit current
(Isc) studies have helped determine the
mechanism by which cholera toxin (18) and other enterotoxins
affect the intestinal mucosa (17, 35). Study of various
types of epithelial cells by using the Ussing chamber model has also
resulted in the identification of numerous microbial substances capable
of directly altering the ion transport capacity of the airway
epithelium (3, 20, 41).
In the present study, control and M. pulmonis-infected mouse
tracheal epithelial cells (MTEs) were evaluated in Ussing chambers. The
results clearly show that M. pulmonis infection directly
alters epithelial ion transport and that this alteration is species
specific, dose and time related, and dependent upon the association of
viable organisms with the apical cell surface.
Mycoplasmas.
Experiments were performed with either a
virulent strain of M. pulmonis, CT, originally isolated
from a mouse with respiratory mycoplasmosis (14), or with
Mycoplasma fermentans incognitus, a mycoplasma of human
origin provided by Shyh-Ching Lo at the Armed Forces Institute of
Pathology, Washington, D.C. Organisms were grown, harvested, and stored
as previously described (46). M. pulmonis
was cultured in mycoplasma broth base (Difco) supplemented with
heat-inactivated and filtered horse serum (HyClone Laboratories, Logan,
Utah) and glucose. After static incubation at 37°C, cultures were
divided into 1-ml aliquots and stored at Animals.
Six-week-old CD-1 mice maintained in Trexler-type
plastic film isolators were used in these studies. The pathogen-free
status of the animals was monitored by culture as previously described (29) for mycoplasmal, viral (Sendai virus, pneumonia virus
of mice, polyomavirus, minute virus of mice, ectromelia virus, mouse hepatitis virus, reovirus 3, Theiler's murine encephalomyelitis virus
strain GD VII, lymphocytic choriomeningitis virus, mouse adenovirus,
sialodacryadenitis virus, Kilham rat virus, and H-1 virus), fungal, and
bacterial pathogens (Charles River Biotechnical Services, Wilmington,
Mass.). The animals were also monitored by an enzyme-linked
immunosorbent assay for serum antimycoplasmal antibodies
(13). The animals were negative for immunoglobulin G and M
antimycoplasmal antibodies and were given sterile food and water ad
libitum.
Isolation and culture of mouse tracheal epithelial cells.
To
study the effect of M. pulmonis on epithelial
electrolyte transport, mouse tracheal epithelial cell cultures were
prepared as previously described (51, 52). Animals were
sacrificed by CO2 inhalation and opened surgically with a
ventral midline incision. The intact trachea was aseptically removed
from the larynx down to just below the bifurcation. The intact trachea was stripped of remaining connective tissue and cut longitudinally to
expose the epithelial cells. Tissues were washed two times with minimal
essential medium (MEM; GIBCO/BRL, Grand Island, N.Y.) and placed in
solution A (MEM, 1% fetal bovine serum [HyClone Laboratories], 0.1%
protease XIV [Sigma Chemical Co., St. Louis, Mo.], 8 U of DNase
[Sigma]) at 4°C for 16 to 24 h with intermittent vortexing.
Cells were recovered by vigorously vortexing the tracheas in solution A
followed by centrifugation at 500 × g for 5 min. The
pelleted cells were resuspended in MTE medium, which was made by mixing
equal volumes of preconditioned medium (Dulbecco's MEM [GIBCO/BRL],
10% fetal bovine serum [recollected after feeding a confluent
monolayer of 3T3 fibroblasts for 2 days], 1% Pen/Strep [GIBCO/BRL])
and solution B (Ham's F-12 medium [GIBCO/BRL] with 1 µg of insulin
per ml, 7.5 µg of transferrin per ml, 1 µM hydrocortisone, 30 nM
3,3'5-triiodo-L-thyronine sodium, 1 ng of cholera toxin per
ml, 2.5 ng of epidermal growth factor per ml, and 10 ng of endothelial
cell growth substance per ml [all purchased from Sigma]). The cell
suspension was seeded onto porous 0.4-µm-pore-size Transwell support
filters (Corning Costar, Cambridge, Mass.) that had been previously
coated with type VI collagen (Sigma). MTE medium was added to the
outside chamber of each filter, and the filters were incubated at
37°C in the presence of 5% CO2. The basolateral medium was replaced with 0.5 ml of MTE medium three times per week for 2 to 3 weeks. The monolayer confluency was monitored by measuring the ability
of the cells to hold back culture medium from their apical surface and
by unidirectional [3H]mannitol flux experiments (4,
5). Monolayers were used in experiments 5 to 6 days later.
Amiloride and furosemide were purchased from RBI (Natick, Mass.),
carbachol was purchased from Sigma, forskolin was obtained from
Calbiochem (San Diego, Calif.), and [3H]mannitol was
purchased from Dupont NEN (Wilmington, Del.).
Infection of epithelial cell monolayers.
For each
experiment, a freshly thawed stock of M. pulmonis was
diluted in MTE conditioned medium. Epithelial cells were apically inoculated with 125 µl of medium that contained a total of 0.5 × 107 to 5.0 × 107 CFU of M. pulmonis (4 × 104 to 4 × 105
CFU/µl). For basolateral infection experiments, the basolateral surface of the filters was exposed to 500 µl of medium which
contained between 2 × 107 and 2 × 108 CFU of M. pulmonis (4 × 104 to 4 × 105 CFU/µl). Control filters
were inoculated with sterile mycoplasma culture medium diluted in MTE
conditioned medium at the same ratio. Minion et al. have previously
reported that a substantial number of M. pulmonis cells
become cell associated within an hour after infection (25).
Furthermore, we have also determined that mycoplasma adherence to
eukaryotic cells does not increase significantly after 6 to 8 h
(unpublished results). As a result of these findings, monolayers were
inoculated with mycoplasma culture medium or control medium and
incubated at 37°C in the presence of 5% CO2 for 6 h unless otherwise described. After incubation, control and
mycoplasma-infected monolayers were washed two times with MTE
conditioned medium (125 µl) and then incubated at an air interface
for an additional 42 h prior to use in Ussing chambers.
Forty-eight hours postinoculation was chosen as the main time point to
evaluate transport on the basis of previous studies by
Städtlander et al. (39) which showed that an
M. pulmonis inoculum of 105 to
107 cells resulted in complete ciliostasis in tracheal
organ cultures within 2 to 3 days. In the shorter time course
experiments, monolayers were similarily exposed to the control or the
mycoplasma inoculum for 6 h, washed, and then incubated at an air
interface for an additional 6 or 12 h. We noted that the filters
assayed at either 12 or 18 h postinfection had 86.3% lower sodium
transport values than those assayed at 48 h. We determined that
this decrease was due to the continued presence of the medium on the
apical surface of the monolayers prior to their use and that this
effect could be reversed if the monolayers were incubated at an air
interface for an additional 12 to 24 h. Widdicombe et al.
(50) recently reported that the continued presence of
culture medium on the apical surface of human tracheal epithelial cells
also caused a decline in their transport response and that the
incubation of these monolayers again at an air interface resulted in
quantitatively normal transport values the following day. We wish to
emphasize that all of the experiments reported here were performed in a paired manner; that is, control and experimental filters were prepared,
handled, and evaluated in parallel, with cells derived from the same
batch of mice.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mycoplasma pulmonis Inhibits
Electrogenic Ion Transport across Murine Tracheal Epithelial Cell
Monolayers
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
secretion and transepithelial resistance. These
effects were shown to require interaction of viable organisms with the
apical surface of the monolayer and to be dependent upon organism
number and duration of infection. Altered transport due to M. pulmonis was not merely a result of epithelial cell death as
evidenced by the following: (i) active transport of Na+ and
Cl
, albeit at reduced rates; (ii) normal cell morphology,
including intact tight junctions, as demonstrated by electron
microscopy; (iii) maintenance of a mean transepithelial resistance of
440
/cm2; and (iv) lack of leakage of fluid from the
basolateral to the apical surface of the monolayer. Alteration in
epithelial ion transport in vitro is consistent with impaired pulmonary
clearance and altered airway function in M. pulmonis-infected animals. Furthermore, the ability of M. pulmonis to alter transport without killing the host cell may
explain its successful parasitism and long-term persistence in the
host. Further study of the MTE-M. pulmonis model should
elucidate the molecular mechanisms which mediate this reduction in
transepithelial ion transport.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
section. Water, in
turn, osmotically follows the transepithelial movement of these ions,
thereby providing a fluid film between the mucus layer and the
epithelial cell surface. The depth and composition of this fluid
microenvironment must be carefully regulated to allow the exchange of
gases and the humidification of the airway epithelium and to ensure
proper mucociliary clearance (47, 49). The consequences of
impaired fluid and electrolyte transport in the airways are strikingly
apparent in cases of cystic fibrosis, a recessive genetic disease
resulting from the loss of epithelial chloride channels (31,
48). The studies reported here were designed to determine whether
M. pulmonis infection alters electrolyte transport across
the murine tracheal epithelium.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
70°C. Quantitation of
mycoplasmas was performed as previously described (1).
Specimens were diluted in Hayflick's broth by serial 10-fold steps
(color-changing units [CCU]), and 0.01 ml of each dilution was
inoculated in duplicate onto Hayflick's agar plates (21).
The serial dilutions and inoculated plates were incubated at 37°C for
6 to 8 days, and the number of CFU was determined. For quantification
of organisms associated with MTEs and demonstration of their growth
over time, filters apically inoculated with M. pulmonis
for 6 h were washed twice to remove any unadhered organisms and
then incubated at 37°C. At 24, 48, 72, and 96 h postinoculation,
mycoplasma-infected filters were aseptically removed and vortexed in
mycoplasma media, and the number of CFU was determined.
Evaluation of ion transport. Ussing chamber Isc experiments were performed as previously described (4, 5). After the filter was mounted between the two half-chamber compartments, the apical compartment and then the basolateral compartment were filled with 4.0 ml of prewarmed Ringer's solution (pH 7.4) composed of 120 mM NaCl, 25 mM NaHCO3, 3.3 mM KH2PO4, 0.83 mM K2HPO4, 1.2 mM CaCl2, and 1.2 mM MgCl2. Glucose (10 mM) was added to the serosal bath, and mannitol (10 mM) was added to the mucosal bathing fluid to eliminate any Na+ current arising from the Na+-glucose cotransporter. Circulation of the solution was accomplished by a gas lift with 95% O2-5% CO2 in both half-chamber compartments, and the temperature was maintained at 37°C by a water jacket. The transmural potential difference (PD) was measured by using 1 M KCl-3% agar bridges. The system was voltage clamped at a zero transmural potential by passing a direct current equal and opposite to the spontaneous PD by using Ag or AgCl electrodes via 1 M KCl-3% agar bridges. The amount of continuous current which is required to nullify the PD is referred to as the Isc and is equal to the sum of all net ionic active-transport processes across the epithelium. The fluid resistance was compensated for prior to the start of the experiment. A 5-mV pulse was applied every 100 s to determine the monolayer resistance, which was calculated by using Ohm's law and is reported in ohms per square centimeter. Measurements were digitally recorded with the aid of an analog-to-digital converter and saved on a computer hard drive.
The following experimental protocol was utilized to assess the Na+ absorptive and Cl
secretory capacity of
the uninfected (control) and M. pulmonis-infected monolayers. Under standard culture conditions, the murine respiratory epithelial monolayers are inherently Na+ absorptive. When
the MTE filter was mounted in the Ussing chamber, the magnitude of
transepithelial Na+ current was determined by adding
amiloride (10 µM) to the mucosal bathing solution. The current
inhibited by amiloride is referred to hereafter as the
amiloride-sensitive Na+ current
(INa+). After 10 to 15 min, forskolin (10 µM) was added to both the apical and basolateral surfaces of the
monolayer to stimulate cyclic AMP (cAMP)-dependent Cl
secretion (ICl
cAMP). To determine
the calcium-mediated Cl
current stimulated across the MTE
monolayer following pretreatment with amiloride and forskolin,
carbachol (100 µM) was added to the basolateral membrane and resulted
in a rapid but transient peak in chloride secretion across the
monolayer, which is reported in the following experiments as the
peak-carbachol current (ICl
peak). Since the level of cholinergic-stimulated Cl
current was
not stable but declined with time, the current which remained 5 min
after the addition of carbachol was also measured (ICl
peak
5). After an
additional 15 min, furosemide (10 µM) was added to the basolateral
solution to inhibit the
Na+-K+-2Cl
cotransporter. This
abolished any remaining current across the monolayer and ended the
experiment.
Electron microscopy. Preparation of ultrathin sections was performed as previously described (39). Briefly, MTE monolayers were incubated with either M. pulmonis or sterile mycoplasma medium for 6 h at 37°C, washed two times in Dulbecco's phosphate-buffered saline, and then incubated for an additional 42 h at 37°C. The filters were then prefixed with 1.5% glutaraldehyde for 90 min at 4°C. After the removal of the aldehyde, the filters were washed and stored in phosphate-buffered saline prior to the secondary fixation with 1% osmium tetroxide at room temperature. Dehydration was performed for a graded series of ethanol-water solutions, and specimens were transferred to propylene oxide and embedded in epoxy resin. Ultrathin sections were cut and stained by standard methods and examined as previously described (39).
Statistical analysis. Results are presented as the means ± standard errors of the means (SEMs). Effects attributable to experimental manipulations were assessed for statistical significance by employing Student's t test for paired and unpaired data, as appropriate. Experimental treatment effects were considered statistically significant if the probability of a type I error was <0.05 or as otherwise noted.
| |
RESULTS |
|---|
|
|
|---|
Inhibition of epithelial ion transport by M. pulmonis.
Strikingly different Isc profiles
were observed when control (mock-infected) and M. pulmonis-infected MTEs were evaluated for Na+
absorption and Cl
secretion in Ussing chambers (Fig.
1). Prior to the addition of amiloride,
the control MTE monolayer mounted in Ussing chambers displayed a
resistance of 2,336
/cm2 and an
Isc across the monolayer of 27.0 µA/cm2 (Fig. 1A). The addition of amiloride to the apical
buffer rapidly reduced the Isc to 7.1 µA/cm2, resulting in the identification of an
INa+ of 19.9 µA/cm2.
Forskolin caused an increase in the Isc of 11.4 µA/cm2, referred to here as the
ICl
cAMP. Carbachol, a
Ca2+-mediated agonist, rapidly increased the
Isc to a peak value of 78.6 µA/cm2. Subtraction of the
ICl
cAMP from this total increase
resulted in an ICl
peak of 67.2 µA/cm2. The
ICl
peak
5 was
similarly calculated and found to be 38.6 µA/cm2. After
an additional 10 to 15 min, the addition of furosemide to the
basolateral solution reduced the Isc to 21.4 µA/cm2, verifying that the Isc was
due to net Cl
secretion. MTE monolayers that had been
infected with M. pulmonis were similarily evaluated and
demonstrated a dramatic decrease in transepithelial ion transport (Fig.
1A and D). After monolayers were infected with an initial inoculum of
1.9 × 107 CFU (Fig. 1D), the
INa+ was 1.8 µA/cm2, and the
ICl
cAMP,
ICl
peak, and
ICl
peak
5 values were 4.29, 11.4, and 6.8 µA/cm2, respectively. The results of 13 to 16 additional experiments are summarized in Table
1. In addition, the transepithelial
resistance of infected monolayers was also substantially altered. These
monolayers displayed a resistance of only 440 ± 87
/cm2 (mean ± SEM). Unidirectional
[3H]mannitol flux studies revealed a 2.1-fold-higher flux
across M. pulmonis-inoculated monolayers (2.3 ± 0.33 nmol, n = 4) than across control monolayers
(1.1 ± 0.21 nmol, n = 4) (P < 0.01). These results are consistent with the 5.4-fold-lower resistance of the M. pulmonis-infected monolayers described above
and confirm that M. pulmonis significantly decreases
the paracellular resistance of the MTE monolayers. In contrast to the
results described above in which the apical surface was infected,
paired experiments in which the basolateral surface of the MTEs was
exposed to either the control medium or the mycoplasma inoculum (2 × 107 to 2 × 108 CFU, n = 6) were also performed. The Isc values for
monolayers exposed basolaterally to the control inoculum included an
INa+ of 23.4 ± 2.8 µA/cm2, an
ICl
cAMP of 11.9 ± 1.5 µA/cm2, and an ICl
peak
of 108.0 ± 12.5 µA/cm2 at 48 h.
Prior to the assessment of the transport capacity of the MTE filters
that had been basolaterally infected with M. pulmonis, the basolateral feeding medium was cultured to determine the number of
CCU of M. pulmonis present. Approximately
106 CCU of M. pulmonis were routinely
recovered from the basolaterally infected filters which displayed
an INa+ of 24.5 ± 1.7 µA/cm2, an ICl
cAMP of
11.5 ± 1.6 µA/cm2, and an
ICl
peak of 118.8 ± 8.2 µA/cm2. These results indicate that exposure of the
basolateral surface of the monolayer of M. pulmonis did
not alter electrogenic ion transport.
|
|
/cm2, which is 20 times greater than fluid resistance; (ii) lack of leakage of fluid from
the basolateral to the apical surface; and (iii) normal cell
morphology, including intact tight junctions, as demonstrated by
electron microscopy performed at the time of altered ion transport.
Transmission electron micrographs of control MTEs revealed a confluent
monolayer of uniform, columnar epithelial cells characterized by tight
junctions, microvilli, and a highly convoluted basolateral membrane
(data not shown). These characteristics are consistent with the high
electrical resistance measured in the Ussing chambers. MTEs examined as
late as 48 h after M. pulmonis infection were
morphologically identical to the control monolayers (data not shown).
Mycoplasmas were not observed in association with the epithelial cells;
however, quantitative cultures of infected monolayers documented that
the organisms were not only present but also replicating (Table
2). Since the number of epithelial cells
comprising the confluent monolayer was estimated to be 3.0 × 105, at 48 h postinoculation, the number of
mycoplasmas per cell (i.e., approximately 17) may not be easily
detectable by electron microscopy.
|
Effect of organism number and duration of exposure.
Increasing
the number of M. pulmonis cells in the infecting
inoculum resulted in a dose-dependent decrease in both ion transport and transepithelial resistance at 48 h (Fig. 1). The length of exposure of the monolayer to the M. pulmonis inoculum
was also varied so that shorter incubation times could be evaluated.
Monolayers that were inoculated with M. pulmonis for 1, 3, or 6 h, washed, and immediately assayed displayed a dramatic
time-dependent decline in their Isc profile
compared to that of the control filters (Fig. 2). The monolayers exposed for 6 h
displayed a mean transepithelial resistance of only 53
/cm2, whereas the controls maintained a resistance of
1,571
/cm2. In addition, the infected monolayers did not
display Na+ transport and no longer responded to
pharmacological stimulators of Cl
secretion.
Interestingly, 6-h-infected MTEs that were washed and allowed to
recover for an additional 18 h displayed resistance values of
1,434 ± 439
/cm2 (n = 10). These
values were similar to those of the control MTEs of 1,746 ± 312
/cm2 (n = 14) (Fig. 2).
|
Viable organisms are required for inhibition of ion transport. Experiments were performed to determine if inhibition of electrolyte transport was due to a substance released by the mycoplasmas into the medium in which they were grown. MTEs were exposed for 6 h to mycoplasma culture supernatants or uninoculated culture medium. The monolayers were washed and then incubated for an additional 42 h. No differences in Isc values were observed (Fig. 3A). To determine if mycoplasma-conditioned culture medium had an acute affect on ion transport, MTEs were exposed to culture supernatants for 1, 3, and 6 h, washed, and immediately assayed. The ion-transporting capacity of these acutely exposed monolayers was also not statistically different from that of the control monolayers exposed to uninoculated mycoplasma medium for the same intervals (n = 3) (data not shown). These results indicate that altered transport requires interaction with an organism.
|
Nonmurine mycoplasma does not affect ion transport. To determine if the effects of the M. pulmonis inoculum were mycoplasma species specific, a nonmurine mycoplasma was evaluated for its ability to alter transepithelial ion transport by using conditions identical to those described above for M. pulmonis. M. fermentans, a mycoplasma of human origin, was used to inoculate MTEs in numbers ranging from 5 × 105 to up to 60-fold greater than those used for M. pulmonis. M. fermentans had no effect on epithelial transport, despite the recovery of large numbers of M. fermentans from infected filters at 48 h (Table 2). The transepithelial resistance of the M. fermentans-inoculated monolayers was also not significantly different from the controls.
| |
DISCUSSION |
|---|
|
|
|---|
Previous in vitro studies have indicated that M. pulmonis can attach to eukaryotic cells within 1 h of
exposure (25). The results presented here provide evidence
that upon interaction with the respiratory epithelium, M. pulmonis may rapidly alter the electrolyte composition of the
fluid layer which lines the airways of its natural host. A 1-h exposure
of MTEs to M. pulmonis resulted in a substantial
decrease in its ion-transporting capacity and its electrical
resistance. As the length of exposure to the inoculum was increased,
both transport functions continued to decrease. MTEs inoculated with
M. pulmonis for 6 h and then immediately assayed
had lost all detectable transport function and almost all
transepithelial resistance. Those that were exposed to the inoculum for
6 h, washed, and then incubated for an additional 18 h
recovered all of their transepithelial resistance and some of their
active-transport capacity. Thus, a 6-h exposure severely compromised
the barrier integrity and transport capacity but did not kill the
epithelial cells. Several explanations may account for the
observed recovery of the monolayer resistance as well as the partial
recovery of active transport. The first suggests that the number of
organisms associated with the monolayer directly influences
its transport capacity. Washing the monolayer after a 6-h exposure to
the inoculum may have removed most of the M. pulmonis
cells unassociated with the monolayer, thereby allowing it to
recover. Forty-eight hours after inoculation, another significant decrease in the resistance of the monolayers occurred. This was again
consistent with a measured increase in the number of M. pulmonis cells associated with the monolayer. A second explanation suggests the intriguing possibility that the interaction of
M. pulmonis with the monolayer may cause a change in
the population of mycoplasma cells. Adherence to the monolayer could
induce or select for a less cytopathic population of organisms,
allowing the epithelium to survive and reestablish ion transport but at a much reduced level. In these studies, the switching of the organisms from liquid culture media to an air-epithelium interface could trigger
a phenotypic change in the cell-associated population. This explanation
is consistent with previous studies that have shown that in infected
animals M. pulmonis undergoes both phenotypic and
genotypic changes which are associated with chronicity (37, 45). In contrast to the transepithelial resistance, when the monolayer's capacity for Na+ absorption or
Cl
secretion was inhibited, transport of neither pathway
returned to control levels. These results suggest that the decrease in transepithelial resistance and the inhibition of electrogenic ion
transport by M. pulmonis may be independently mediated.
Together, these studies indicate that the addition of M. pulmonis to the apical surface of MTEs rapidly alters both epithelial barrier integrity and transport function. The failure of M. pulmonis to affect ion transport from the basolateral side reinforces the importance of interaction with the apical surface and is consistent with in vivo studies of mice which suggest that M. pulmonis remains limited to the apical surface, i.e., it is rarely found in the submucosa (39). The epithelial cells were grown on a 0.4-µm-pore-size filter, and it is possible that the filter precluded the interaction of the mycoplasmas with the basolateral cell surface despite their small cellular size (180 to 300 nm) and their plasticity associated with the lack of a cell wall (44). M. pulmonis cells (106/ml) were recovered from the basolateral medium after a 48-h incubation, indicating that their presence on the basolateral side was insufficient to alter transport. We were unsuccessful in our attempts to grow MTEs on a more porous support (4.0-µm pore size) to test further whether MTE-M. pulmonis contact at the basolateral membrane would alter transport.
Other investigators have previously shown that M. fermentans, a mycoplasma of human origin, does not cause cytopathic effects in mice following intranasal inoculation or in murine tracheal organ cultures (40). Consistent with these results, ion transport was also not altered when the MTE monolayers were infected with M. fermentans, despite the large numbers of M. fermentans cells recovered from the monolayers at 48 h postinfection. Thus, the presence of mycoplasma cells per se does not lead to the alterations observed in the MTEs but rather suggests that a species-specific interaction between M. pulmonis and the MTE monolayer would seem to be required. To verify this, additional species of mycoplasma must be studied in the MTE monolayer system.
Although several potential pathogenic factors have been identified in
the mycoplasmas, including peroxidases (10), endonucleases (30, 32), phospholipases (16, 34), and a
membrane-associated hemolytic activity (10, 27), the
molecular mechanisms by which M. pulmonis colonizes the
respiratory epithelium and establishes chronic airway disease are
unknown. Exposure of the monolayers to M. pulmonis
culture supernatants did not alter Na+ absorption,
Cl
secretion, or the resistance of the MTEs. These
results indicate that the M. pulmonis component
responsible for the alterations in electrogenic ion transport and the
decrease in epithelial resistance of the MTE monolayer is not released
by M. pulmonis cells under normal laboratory culture
conditions but requires the intact organism. Additional studies will be
needed, however, to determine if the inhibiting activity is selectively
secreted by mycoplasma cells upon contact with the epithelium. Several
studies have examined the pathogenic potential of purified mycoplasma
membranes, cell lysates, and nonviable organisms (2, 12, 19,
26). In our studies, M. pulmonis cells that were
killed by UV treatment were no longer able to inhibit the absorption or
secretion of ions or to decrease the transepithelial resistance of the
monolayer.
Numerous researchers have reported that the infection of tracheal organ
cultures with mycoplasmas results in ciliostasis, loss of tight
junctions, and in most cases the complete exfoliation of the
respiratory epithelium (2, 9, 11, 15, 24, 39). This study,
in contrast, evaluated the electrogenic ion transport capacity of MTEs
infected with M. pulmonis and reveals that this organism causes much more subtle changes in the respiratory epithelium than have previously been observed by other investigators. The inhibition of Na+ absorption and Cl
secretion
and the concomitant loss in resistance of the epithelial monolayer
suggest that M. pulmonis infection leads to the
formation of a new functional steady state in which the monolayer
continues to absorb and secrete fluid and electrolytes but at a much
reduced level. The pathophysiological consequences of this reduced
functional state are a change in the volume and composition of the
fluid which bathes the airways. This could, in turn, compromise ciliary movement and mucus hydration and ultimately lead to a reduction in
mucociliary clearance.
Ion transport across the epithelial monolayer is a highly complex and
tightly regulated molecular cross talk between extracellular signals,
intracellular second messengers, and the transport proteins in the
apical and basolateral cell membranes. Therefore, the modulation of ion
transport and transepithelial resistance by M. pulmonis could occur at a variety of sites. The absorption and secretion of
fluid and electrolytes across the respiratory epithelium involve the
coordinated movement of ions across the apical and basolateral membranes through highly selective Na+, Cl
,
and K+ channels, the Na+-K+ pump,
and the Na+-K+-2Cl
cotransporter,
any of which could be directly or indirectly affected during
mycoplasmal infection. The ability of M. pulmonis to
alter host cell second messengers is a logical explanation for the
observed decrease in both Na+ and Cl
transport; however, the factors mediating these alterations have yet to
be clearly addressed for any mycoplasma species (36). Both
Na+ and Cl
were inhibited in our studies,
suggesting that M. pulmonis may alter a single step
which is central to both pathways (e.g., the basolateral K+
channel). This notion is supported by the recent studies of Izutsu et
al., who showed that Mycoplasma orale infection affects the expression and regulation of K+ channels in the surface
membrane of a human submandibular gland cell line (22).
Recent studies by Smith et al. (38) indicate that pathogenic microorganisms may persist in the airways of patients with cystic fibrosis because bacteriocidal factors normally produced by the respiratory epithelium are inactivated by abnormal salt concentrations. Our results suggest that the ability of M. pulmonis to alter transepithelial ion transport may allow it to escape killing by a similar mechanism. This is further supported by the fact that M. pulmonis-infected animals are incapable of clearing the organism from the respiratory epithelium and are also highly susceptible to secondary infections. It is safe to assume that the pathophysiology which underlies chronic mycoplasmal infections is undoubtedly complex and multifactorial in origin. The methodologies described herein may be useful in determining which pathogenic factors are involved and, in turn, guide us toward the most logical approach for therapy against persistent mycoplasmal diseases.
| |
ACKNOWLEDGMENTS |
|---|
We are greatly indebted to Eugene Arms, Jeff Ervin, and Darin Steele for excellent technical assistance. We thank Dan Devor and Bruce Schultz for their helpful discussions.
This work was supported in part by grant AI 33197 to G.H.C. from the National Institute of Allergy and Infectious Disease and grant DK 45970 to R.J.B. from the National Institute of Diabetes and Digestive and Kidney Diseases. R.J.B. is a Cystic Fibrosis Foundation Research Scholar. L.C.L. was supported by training grant 732 HL 07553 to G.H.C. from the National Heart, Lung, and Blood Institute.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: S362 BST, 3500 Terrace St., Department of Cell Biology and Physiology, The University of Pittsburgh, Pittsburgh, PA 15261. Phone: (412) 648-1075. Fax: (412) 648-2844. E-mail: bbridges+{at}pitt.edu.
Editor: J. G. Cannon
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Albers, A. C., and R. D. Fletcher.
1982.
Simple method for quantitation of viable mycoplasmas.
Appl. Environ. Microbiol.
43:958-960 |
| 2. | Araake, M. 1982. Comparison of ciliostasis by mycoplasmas in mouse and chicken tracheal organ cultures. Microbiol. Immunol. 26:1-14[Medline]. |
| 3. | Ball, J. M., P. Tian, C. Q.-Y. Zeng, A. P. Morris, and M. K. Estes. 1996. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 272:101-104[Abstract]. |
| 4. |
Bridges, R. J.,
G. Nell, and W. Rummel.
1983.
Influence of vasopressin and calcium on electrolyte transport across isolated colonic mucosa of the rat.
J. Physiol.
338:463-475.
|
| 5. |
Bridges, R. J.,
W. Rummel, and P. Wollenberg.
1984.
Effects of vasopressin on electrolyte transport across isolated colon from normal and dexamethasone-treated rats.
J. Physiol.
355:11-23.
|
| 6. |
Cassell, G. H.,
J. K. Davis,
W. H. Wilborn, and K. S. Wise.
1978.
Pathobiology of mycoplasmas, p. 399-403. In
D. Schlessinger (ed.), Microbiology 1978.
American Society for Microbiology, Washington, D.C.
|
| 7. | Cassell, G. H., and A. Hill. 1979. Murine and other small animal mycoplasmas, p. 235-273. In J. G. Tully, and R. F. Whitcomb (ed.), The mycoplasmas, vol. II. Academic Press, Inc., New York, N.Y. |
| 8. | Cassell, G. H., W. A. Clyde, Jr., and J. K. Davis. 1985. Mycoplasmal respiratory infections, p. 69-106. In M. F. Barile, S. Razin, J. G. Tully, and R. F. Whitcomb (ed.), The mycoplasmas, vol. IV. Academic Press, Inc., New York, N.Y. |
| 9. |
Cherry, J. D., and D. Taylor-Robinson.
1970.
Growth and pathogenesis of Mycoplasma mycoides var. capri in chicken embryo tracheal organ cultures.
Infect. Immun.
2:431-438 |
| 10. |
Cole, B. C.,
J. R. Ward, and C. H. Martin.
1968.
Hemolysin and peroxide activity of mycoplasma species.
J. Bacteriol.
95:2022-2030 |
| 11. | Collier, A. M., W. A. Clyde, Jr., and F. W. Denny. 1969. Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture (34385). Proc. Soc. Exp. Biol. Med. 132:1153-1158[Medline]. |
| 12. |
Davidson, M. K.,
J. K. Davis,
J. R. Lindsey, and G. H. Cassell.
1988.
Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice.
Infect. Immun.
56:2163-2168 |
| 13. |
Davis, J. K.,
J. W. Simecka,
J. S. P. Williamson,
S. E. Ross,
M. M. Juliana,
R. B. Thorpe, and G. H. Cassell.
1985.
Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences.
Infect. Immun.
49:152-158 |
| 14. |
Davis, J. K.,
R. B. Thorpe,
R. F. Parker,
H. White,
D. Dziedzic,
J. D'Arcy, and G. H. Cassell.
1986.
Development of an aerosol model of murine respiratory mycoplasmosis in mice.
Infect. Immun.
54:194-201 |
| 15. |
DeBey, M., and R. F. Ross.
1994.
Ciliostasis and loss of cilia induced by Mycoplasma hyopneumonia in porcine tracheal organ cultures.
Infect. Immun.
62:5312-5318 |
| 16. |
De Silva, N. S., and P. A. Quinn.
1991.
Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum.
J. Clin. Microbiol.
29:1493-1503 |
| 17. |
Fasano, A.,
B. A. Kay,
R. G. Russell,
D. R. Maneval, Jr., and M. M. Levine.
1990.
Enterotoxin and cytotoxin production by enteroinvasive Escherichia coli.
Infect. Immun.
58:3717-3723 |
| 18. | Field, M., D. Fromm, Q. Al-Awqati, and W. B. Greenough, III. 1972. Effect of cholera enterotoxin on ion transport across ileal mucosa. J. Clin. Invest. 51:796-804. |
| 19. |
Gaybridge, M. G.,
C. K. Johnson, and A. M. Cameron.
1974.
Cytotoxicity of Mycoplasma pneumoniae membranes.
Infect. Immun.
10:1127-1134 |
| 20. | Graham, A., D. M. Steel, R. Wilson, P. J. Cole, E. W. F. W. Alton, and D. M. Geddes. 1993. Effects of purified pseudomonas rhamnolipids on bioelectric properties of sheep tracheal epithelium. Exp. Lung Res. 19:77-89[Medline]. |
| 21. | Hayflick, L. 1965. Tissue cultures and mycoplasmas. Tex. Rep. Biol. Med. 23(Suppl. 1):285-303. |
| 22. |
Izutsu, K. T.,
S. Fatherazi,
C. M. Belton,
D. Oda,
F. D. Cartwright, and G. E. Kenny.
1996.
Mycoplasma orale infection affects K+ and Cl currents in the HSG salivary gland cell line.
In Vitro Cell. Dev. Biol.
32:361-365.
|
| 23. | Lindsey, J. R., H. J. Baker, R. G. Overcash, G. H. Cassell, and C. E. Hunt. 1971. Murine chronic respiratory disease. Significance as a research complication and experimental production with M. pulmonis. Am. J. Pathol. 64:675-716[Medline]. |
| 24. | Lindsey, J. R., and G. H. Cassell. 1973. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am. J. Pathol. 72:63-90[Medline]. |
| 25. |
Minion, F. C.,
G. H. Cassell,
S. Pnini, and I. Kahane.
1984.
Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination.
Infect. Immun.
44:394-400 |
| 26. |
Minion, F. C., and J. D. Goguen.
1986.
Identification and preliminary characterization of external membrane-bound nuclease activity in Mycoplasma pulmonis.
Infect. Immun.
51:352-354 |
| 27. | Minion, F. C., and K. Jarvill-Taylor. 1994. Membrane-associated hemolysin activities in mycoplasmas. FEMS Microbiol. Lett. 116:101-106[Medline]. |
| 28. |
Organick, A. B.,
K. A. Siegesmund, and I. I. Lutsky.
1966.
Pneumonia due to Mycoplasma in gnotobiotic rats. II. Localization of Mycoplasma pulmonis in the lungs of infected gnotobiotic mice by electron microscopy.
J. Bacteriol.
92:1164-1176 |
| 29. |
Parker, R. F.,
J. K. Davis,
D. K. Blalock,
R. B. Thorp,
J. W. Simecka, and G. H. Cassell.
1987.
Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.
Infect. Immun.
55:2631-2635 |
| 30. |
Pollak, J. D., and P. J. Hoffman.
1982.
Properties of the nucleases of mollicutes.
J. Bacteriol.
152:538-541 |
| 31. |
Quinton, P. M.
1989.
Defective epithelial ion transport in cystic fibrosis.
Clin. Chem.
35:726-730 |
| 32. |
Razin, S.,
A. Knyszynski, and Y. Lifschitz.
1964.
Nucleases of mycoplasma.
J. Gen. Microbiol.
36:323-332 |
| 33. |
Ross, S. E.,
J. W. Simecka,
G. P. Gambill,
J. K. Davis, and G. H. Cassell.
1992.
Mycoplasma pulmonis possesses a novel chemoattractant for B lymphocytes.
Infect. Immun.
60:669-674 |
| 34. | Salaman, M., and S. Rottem. 1995. The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity. Biochim. Biophys. Acta 1235:369-377[Medline]. |
| 35. | Savarino, S. J., A. Fasano, D. C. Robertson, and M. M. Levine. 1991. Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J. Clin. Invest. 87:1450-1455. |
| 36. | Simecka, J. W., J. K. Davis, M. K. Davidson, S. E. Ross, C. T. K.-H. Städtlander, and G. H. Cassell. 1992. Mycoplasma diseases of animals, p. 391-415. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C. |
| 37. | Simmons, W., Z. Cao, J. Glass, H. L. Watson, and G. H. Cassell. 1994. Comparison of the V-1 genes from two Mycoplasma pulmonis variants that differ with respect to disease potential. IOM Lett. 3:557-558. |
| 38. | Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236[Medline]. |
| 39. |
Städtlander, C. T. K.-H.,
H. L. Watson,
J. W. Simecka, and G. H. Cassell.
1991.
Cytopathic effects of Mycoplasma pulmonis in vivo and in vitro.
Infect. Immun.
59:4201-4211 |
| 40. | Städtlander, C. T. K.-H., H. L. Watson, J. W. Simecka, and G. H. Cassell. 1993. Cytopathogenicity of Mycoplasma fermentans (including strain incognitus). Clin. Infect. Dis. 17(Suppl. 1):S289-S301. |
| 41. | Stutts, M. J., J. H. Schwab, M. G. Chen, M. R. Knowles, and R. C. Boucher. 1986. Effects of Pseudomonas aeruginosa on bronchial epithelial ion transport. Am. Rev. Respir. Dis. 134:17-21[Medline]. |
| 42. | Taylor, G., and D. Taylor-Robinson. 1974. Humoral and cell-mediated immune mechanisms in mycoplasma infections. Colloq. INSERM 33:331-336. |
| 43. | Taylor-Robinson, D., H. U. Schorlemmer, P. M. Furr, and A. C. Allison. 1978. Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms. Clin. Exp. Immunol. 33:486-494[Medline]. |
| 44. | Tully, J. G., and R. F. Whitcomb (ed.). 1979. , p. 509. The mycoplasmas, vol. II. Human and animal mycoplasmas. Academic Press, Inc., New York, N.Y. |
| 45. |
Watson, H. L.,
L. S. McDaniel,
D. K. Blalock,
M. T. Fallon, and G. H. Cassell.
1988.
Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis.
Infect. Immun.
56:1358-1365 |
| 46. | Watson, H. L., D. K. Blalock, and G. H. Cassell. 1990. Relationship of hydrophobicity of the V-1 antigen of Mycoplasma pulmonis to adherence. Zentralbl. Bakteriol. Suppl. 20:650-654. |
| 47. |
Welsh, M. J.
1987.
Electrolyte transport by airway epithelia.
Physiol. Rev.
67:1143-1184 |
| 48. | Widdicombe, J. H. 1987. Altered chloride transport of tracheal epithelium in cystic fibrosis. Prog. Clin. Biol. Res. 254:115-126[Medline]. |
| 49. | Widdicombe, J. H., S. S. Miller, and W. E. Finkbeiner. 1994. Altered regulation of airway fluid content in cystic fibrosis, p. 109-129. In J. A. Dodge, D. J. H. Brock, and J. H. Widdicombe (ed.), Cystic fibrosis: current topics, vol. 2. John Wiley & Sons, Inc., New York, N.Y. |
| 50. |
Widdicombe, J. H.,
F. Azizi,
T. Kang, and J. F. Pittet.
1996.
Transient permeabilization of airway epithelium by mucosal water.
J. Appl. Physiol.
81:491-499 |
| 51. | Wu, R., J. W. Groelke, L. Y. Chang, M. E. Proter, D. Smith, and P. Nettesheim. 1982. Effects of hormones on the multiplication and differentiation of tracheal epithelial cells in culture, p. 641-656. In D. Sirbasku, et al. (ed.), Growth of cells in hormonally defined media. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 52. | Wu, R., J. Yankaskas, E. Cheng, M. R. Knowles, and R. Boucher. 1985. Growth and differentiation of human nasal epithelial cells in culture. Am. Rev. Respir. Dis. 132:311-320[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»